Linical Co., Ltd.

TSE:2183 Stock Report

Market Cap: JP¥7.9b

Linical Management

Management criteria checks 0/4

Linical's CEO is Kazuhiro Hatano, appointed in Jun 2005, has a tenure of 19.67 years. directly owns 23.22% of the company’s shares, worth ¥1.82B. The average tenure of the management team and the board of directors is 1.1 years and 1.7 years respectively.

Key information

Kazuhiro Hatano

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure19.7yrs
CEO ownership23.2%
Management average tenure1.1yrs
Board average tenure1.7yrs

Recent management updates

Recent updates

Linical (TSE:2183) Is Increasing Its Dividend To ¥16.00

Jan 03
Linical (TSE:2183) Is Increasing Its Dividend To ¥16.00

Linical's (TSE:2183) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 01
Linical's (TSE:2183) Shareholders Will Receive A Bigger Dividend Than Last Year

Linical's (TSE:2183) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 17
Linical's (TSE:2183) Shareholders Will Receive A Bigger Dividend Than Last Year

There May Be Some Bright Spots In Linical's (TSE:2183) Earnings

May 22
There May Be Some Bright Spots In Linical's (TSE:2183) Earnings

Some Linical Co., Ltd. (TSE:2183) Shareholders Look For Exit As Shares Take 26% Pounding

Mar 08
Some Linical Co., Ltd. (TSE:2183) Shareholders Look For Exit As Shares Take 26% Pounding

Linical (TSE:2183) Is Paying Out A Larger Dividend Than Last Year

Feb 26
Linical (TSE:2183) Is Paying Out A Larger Dividend Than Last Year

CEO

Kazuhiro Hatano (59 yo)

19.7yrs

Tenure

Mr. Kazuhiro Hatano has been the Chief Executive Officer and Director at Linical Co. Ltd. since June 2005, serves as its Chief Strategy Officer since August 2024, serves as its Chief Commercial Officer and...

Leadership Team

NamePositionTenureCompensationOwnership
Kazuhiro Hatano
President19.7yrsno data23.22%
¥ 1.8b
Rebecca Lamborn
Chief Financial Officerless than a yearno datano data
Tokuno Masayoshi
Chief Information Officerless than a yearno datano data
Jun Kawai
Chief Administrative Officerless than a yearno data2.66%
¥ 208.8m
Keigo Tsujimoto
Executive Officer & Chief Project Officer13.6yrsno data4.53%
¥ 356.4m
Masaya Miyazaki
Chief Asia Pacific Officer17.8yrsno data2.66%
¥ 208.8m
Clareece West
President & Chief Commercial Officer of Americas & Europe1.1yrsno datano data
Tracy Goeken
Chief Medical Officerno datano datano data
Satoru Toyota
Executive Officer & Head of Oncology Business Unit (HQno datano datano data
Tomoko Inomata
Executive Officer & Head of Primary Business Unit (HQno datano datano data
Tyler Cochran
Chief Compliance Officer of Americas & Europeno datano datano data
Heidi Miller
Senior Vice President of Clinical Operations of Americas & Europeno datano datano data

1.1yrs

Average Tenure

57.5yo

Average Age

Experienced Management: 2183's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Kazuhiro Hatano
President19.7yrsno data23.22%
¥ 1.8b
Kyoichi Shimomura
Independent Outside Director1.7yrsno datano data
Eri Sugiyama
Independent Outside Director1.7yrsno datano data
Yoshiaki Nakashima
Independent Outside Director1.7yrsno datano data
Yuichi Murakami
Independent Outside Director1.7yrsno datano data
Yoshimitsu Ando
Independent Outside Director1.7yrsno datano data
Satoko Nishimura
Independent Outside Director1.7yrsno datano data

1.7yrs

Average Tenure

66yo

Average Age

Experienced Board: 2183's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 08:03
End of Day Share Price 2025/02/07 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Linical Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Masao YoshidaIchiyoshi Research Institute Inc.
Michael NewmanMacquarie Research
Yasunori HiromotoMarusan Securities Co. Ltd.